Form 4: Clene Inc. Insider Sells 78,679 Shares
Statement of Changes in Beneficial Ownership
Reporting person Chidozie Ugwumba sold a total of 78,679 shares of Clene Inc. common stock held by SymBiosis II, LLC.
Summary
- Chidozie Ugwumba, a 10% owner of Clene Inc., executed two sales of common stock held by SymBiosis II, LLC.
- On May 1, 2026, 5,795 shares were sold at an average price of $6.01.
- On May 4, 2026, 72,884 shares were sold at an average price of $6.80.
- Following these transactions, the reporting person maintains beneficial ownership of 198,890 shares through SymBiosis II, LLC.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; it is a standard regulatory disclosure of an insider transaction that does not reflect on the company's fundamental business health.
Positives
- The transactions represent a reduction in position by a significant shareholder rather than a company-wide operational change.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in near-term price appreciation.
Risks
- Market liquidity risks associated with large block sales by significant shareholders.
Future Outlook
No forward-looking guidance or operational outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider selling is a common occurrence for venture capital or private equity entities like SymBiosis II, LLC, often related to fund lifecycle management rather than specific company performance indicators.
Comparison to Industry Standards
- Insider sales by 10% owners are standard practice for institutional investors rebalancing portfolios.
- The volume of shares sold is consistent with typical liquidity events for biotech-focused investment firms.
Related Party Transactions
- The shares were held by SymBiosis II, LLC, an entity associated with the reporting person, Chidozie Ugwumba.
Stakeholder Impact
- Minor impact on market sentiment due to the nature of the insider sale.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | First transaction date for the sale of 5,795 shares. |
| 05/04/2026 | Second transaction date for the sale of 72,884 shares. |
| 05/05/2026 | Date of filing. |
Keywords
Clene Inc, CLNN, Insider Trading, Form 4, Stock Sale, SymBiosis II LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.